Private Equity Transactions in the Cannabis Industry
Private equity has been trying to invest in the cannabis industry for some time, but has found some difficulties doing so. In particular because of the structure of private equity. most equity is structured with a handful of general partners. Then dozens if not hundreds of limited partners who hand over their investment to a general partner in exchange for not having to be disclosed and with respect to their investment.
Unfortunately in the cannabis industry, particularly with licensed cannabis businesses, regulators often require all owners including limited partners to disclose their ownership stakes in a licensed cannabis business. This can be very difficult for limited partners of private equity because of the disclosure rules. However, there are ways to deal with these particular issues both with the regulators and in ways of structuring transactions involving private equity.
At McAllister Garfield, we’ve handled a number of private equity transactions and we can assist with yours as well.
Related Article
Psychedelic Therapy & Law Update – April 2026
President Trump to Issue Executive Order on Ibogaine President Trump will sign an executive order opening doors for more federal reserach on ibogaine, the naturally occuring psychedelic substance with indigenous roots in Africa. For more information, see this article by clicking here. Ibogaine has shown significant benefits for veterans suffering from war trauma, those suffering from […]
Psychedelic Therapy & Law Update – March 2026
Colorado starts the rulemaking process again for NMHA program changes DOR Natural Medicine Division is proposing several rules changes to the NMHA rules. These proposed changes include a significant increase in the cost of standard healing center licenses (from $6k to over $10k). Other proposed changes include adding an owner entity fee, prohibiting cultivator sampling […]
Psychedelic Therapy & Law Update – February 2026
Maryland and New Jersey moving toward creation of psilocybin programs The Maryland Task Force on Responsible Use of Natural Psychedelic Substances, in a report near the end of 2025 endorsed the creation of a regulated psilocybin program in the state. The recommendation still needs to be adopted by the Maryland legislature, but this is an […]